flurothyl has been researched along with reboxetine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liles, LC; Schank, JR; Weinshenker, D | 1 |
| Ahern, TH; Eagles, DA; Javors, MA; Liles, LC; Martillotti, J; Mitchell, HA; Weinshenker, D | 1 |
2 other study(ies) available for flurothyl and reboxetine
| Article | Year |
|---|---|
Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Anticonvulsants; Disease Models, Animal; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Combinations; Flurothyl; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Norepinephrine; Reaction Time; Reboxetine; Seizures; Valproic Acid | 2005 |
The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Disease Models, Animal; Dopamine beta-Hydroxylase; Drug Administration Schedule; Electroshock; Flurothyl; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Reaction Time; Reboxetine; Seizures | 2006 |